September 2014

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Indra Prakash¹*, Jugaldas Chudasama², Pravin Gupta¹, Rahul Dev¹, Shashi Shekhar¹, Mohit kumar^2
1Sir Madanlal Institute of Pharmacy, AlampurHauz, Etawah, Uttar Pradesh, India
²Medicef Pharma, Jhar Majri, Baddi, Himachal Pradesh, India
indra.prakash117@gmail.com

ABSTRACT
The objective of present study was to develop the formulation of Fast Dispersible tablet of Amoxycillin & Potassium clavulanate and perform the in vitro bioequivalence study with trying to enhance the bioavailability of innovator formulation. Reduction in the dose of Amoxycillin and potassium clavulanate tablet was possible by developing Fast dispersible tablet. Fast dispersible tablets are designed to disintegrate quickly in the mouth or disperse in a spoonful of water to become a suspension. They are also divided into two or four parts for easy dose titration, and taste masked for patient compliance. These tablets are given to the children who have difficulty in swallowing so Total 05 formulations were made with different concentration of Crospovidone & MCC and fixed concentration of Croscarmellose sodium and Polacrilin Potassium by dry granulation method. The formulations were evaluated for weight variation, hardness, friability, disintegrating time, dissolution study. All the formulations shows uniform weight, hardness and friability data indicates good mechanical resistance of the tablet. All the tablets were disintegrated between 25-45Sec. The optimized (FR-5) formulation showed good disintegration time and release profile with maximum drug being released than marketed preparation at all-time intervals.

Indegene offer scientific partnership to global life science companies by delivering a spectrum of medical, marketing, training, intelligence, and analytics services.  The depth of our scientific expertise, scale of operations, offshore delivery model, global footprint, and intellectual property (IP) help us deliver value across multiple dimensions. We offer cost-effective solutions and services. We have the ability to work with global teams and their local affiliates for marketing and educational programs.

Post: Clinical Trial Analyst

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

Therapeutic effectiveness of a drug depends upon the bioavailability and ultimately upon the solubility of drug molecules. Solubility is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological response to be shown. More than 40% of new candidates entering drug development pipeline fail because of non-optimal biopharmaceutical properties. Over the years, tools of drug discovery have caused a perceptible shift in biopharmaceutical properties.